Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19. | EBioMedicine | 2022 | 35939907 | PubTator, text mining | PubMed |
| Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2. | Struct Chem | 2022 | 35938064 | PubTator, text mining | PubMed |
| Comprehensive analysis of complement-associated molecular features in hepatocellular carcinoma. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35929594 | PubTator, text mining | PubMed |
| Anti-C1q autoantibodies from systemic lupus erythematosus patients enhance CD40-CD154-mediated inflammation in peripheral blood mononuclear cells in vitro. | Clin Transl Immunology | 2022 | 35928801 | PubTator, text mining | PubMed |
| Identification of immune-related biomarkers in embryos with neural tube defects via a bioinformatics analysis. | Ann Transl Med | 2022 | 35928755 | PubTator, text mining | PubMed |
| Serum exosomal coronin 1A and dynamin 2 as neural tube defect biomarkers. | J Mol Med (Berl) | 2022 | 35915349 | PubTator, text mining | PubMed |
| Neuropilin-1 in the pathogenesis of preeclampsia, HIV-1, and SARS-CoV-2 infection: A review. | Virus Res | 2022 | 35905790 | PubTator, text mining | PubMed |
| Unbiased proteomic analysis of extracellular vesicles secreted by senescent human vascular smooth muscle cells reveals their ability to modulate immune cell functions. | Geroscience | 2022 | 35900662 | PubTator, text mining | PubMed |
| Complement System as a New Target for Hematopoietic Stem Cell Transplantation-Related Thrombotic Microangiopathy. | Pharmaceuticals (Basel) | 2022 | 35890144 | PubTator, text mining | PubMed |
| Novel Therapies to Address Unmet Needs in ITP. | Pharmaceuticals (Basel) | 2022 | 35890078 | PubTator, text mining | PubMed |
| Genomic Characterization by Whole-Exome Sequencing of Hypermobility Spectrum Disorder. | Genes (Basel) | 2022 | 35886052 | PubTator, text mining | PubMed |
| Network Proximity-Based Drug Repurposing Strategy for Early and Late Stages of Primary Biliary Cholangitis. | Biomedicines | 2022 | 35884999 | PubTator, text mining | PubMed |
| Non-HLA Antibodies in Kidney Transplantation: Immunity and Genetic Insights. | Biomedicines | 2022 | 35884811 | PubTator, text mining | PubMed |
| A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients. | Cancers (Basel) | 2022 | 35884472 | PubTator, text mining | PubMed |
| Transcriptomic and proteomic retinal pigment epithelium signatures of age-related macular degeneration. | Nat Commun | 2022 | 35882847 | PubTator, text mining | PubMed |
| Dengue Infection - Recent Advances in Disease Pathogenesis in the Era of COVID-19. | Front Immunol | 2022 | 35874775 | PubTator, text mining | PubMed |
| The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy. | Front Immunol | 2022 | 35874690 | PubTator, text mining | PubMed |
| A large-scale polygenic risk score analysis identified candidate proteins associated with anxiety, depression and neuroticism. | Mol Brain | 2022 | 35870967 | PubTator, text mining | PubMed |
| Inside-Out of Complement in Cancer. | Front Immunol | 2022 | 35860237 | PubTator, text mining | PubMed |
| Effects of the complement system on antibody formation and function: implications for transplantation. | Curr Opin Organ Transplant | 2022 | 35857345 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=34